Stroke In Young, Hyperhomocysteine and Associated With COVID-19 Illness- A Case Report

Sagar Gupta

Sagar Gupta DNB Medicine, Fellowship in Critical care medicine, Consultant Physician & Intensivist, Department of Medicine Dr Hedgewar Hospital, Aurangabad, Maharashtra, India. https://orcid.org/0000-0002-9378-1701

Keywords: Stroke in Young, SARS IGG Antibody, Post COVID-19 Sequel, Hyperhomocysteine, Post COVID Thrombotic Complications

Abstract

As COVID-19 patients are at high risk of thrombotic complications this makes physician aware of close monitoring of both neurological status and cardiovascular status. Along with involvement of respiratory system, pathological process carries both inflammation and hyper coagulopathy both simultaneously. Homocystein as high risk predictor of stroke in young which is unmasked due to hypercoaguable state of COVID-19.

How to cite this article:
Gupta S. Stroke In Young, Hyperhomocystine and Associated With COVID-19 Illness- A Case Report. J Adv Res Med 2020; 7(4): 20-23.

DOI: https://doi.org/10.24321/2349.7181.202020

References

Ponti G, Ruini C, Tomasi A. Homocystein as potential predictor as cardiovascular risk in patient with COVID

Med Hypotheses 2020; 143:109859. DOI: 10.1016/j.mehy.2020.109859.

Ansari R, Mahta A, Mallack E et al. Hyperhomocysteinemia and Neurologic Disorders: a Review. Journal of Clinical Neurology 10(4): 281.

Aboo-ismail MY, Diamond A, Kapoor S et al. The hypercoagulable state in COVID 19 incidence,

pathophysiology and management. Thrombosis Research Vol 194: 101-115. https://doi.org/10.1016/j.

thromres.2020.06.029.

Oxley TJ, Mocco J, Majidi S et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young | NEJM.

(2021). NEJM. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMc2009787